IP Library Assignment 057104/0189
Patent Assignment
Reel/Frame 057104/0189

Patent Security Agreement

Recorded: 2021-08-05 Pages: 8
Assignor
OYSTER POINT PHARMA, INC.
Executed: 2021-08-05
Assignee
ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties (24)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3YLVINYL)Pyrimidine
Patent: 8,604,191 →
Application: 13/129,898 →
Publication: US 2011/0281895
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3YLVINYL)Pyrimidine
Patent: 9,145,396 →
Application: 14/074,147 →
Publication: US 2014/0066460
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Patent: 9,981,949 →
Application: 15/354,832 →
Publication: US 2017/0260167
Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 15/962,982 →
Publication: US 2019/0071428
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 16/541,033 →
Publication: US 2020/0207740
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 17/144,884 →
Publication: US 2021/0371401
Novel Compounds
Patent: 8,153,821 →
Application: 13/130,954 →
Publication: US 2011/0269975
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 7,098,331 →
Application: 10/379,868 →
Publication: US 2004/0176348
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 7,714,001 →
Application: 12/187,584 →
Publication: US 2008/0293778
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 8,063,068 →
Application: 12/348,605 →
Publication: US 2010/0010042
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 8,067,443 →
Application: 12/683,106 →
Publication: US 2010/0267776
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 8,633,222 →
Application: 13/033,719 →
Publication: US 2011/0152293
Methods of Increasing Tear Production
Patent: 9,504,644 →
Application: 14/887,243 →
Publication: US 2016/0106744
Dry Eye Treatments
Patent: 9,597,284 →
Application: 14/887,248 →
Publication: US 2016/0106745
Methods of Improving Ocular Discomfort
Patent: 9,532,944 →
Application: 14/887,253 →
Publication: US 2016/0106665
Pharmaceutical Formulations for Treating Ocular Conditions
Patent: 9,504,645 →
Application: 14/887,259 →
Publication: US 2016/0106746
Dry Eye Treatments
Application: 15/422,382 →
Publication: US 2017/0239244
Methods of Increasing Lacrimal Proteins
Application: 16/566,237 →
Publication: US 2020/0246336
Methods of Treating Ocular Conditions
Application: 16/091,830 →
Publication: US 2019/0201397
Methods of Treating Ocular Conditions
Application: 16/852,225 →
Publication: US 2020/0345734
Combinations of Positive Allosteric Modulators and Nicotinic Acetylcholine Receptor Agonists for Treating Ocular Conditions
Application: 17/144,548 →
Publication: US 2021/0379066
Aav Virion Encoding Neurotrophic Factor and Uses Thereof
Application: 63/185,889 →
Co-Therapy with Vector and Nicotinic Agonist
Application: 63/185,897 →
Nesting Structures for Storage, Transport, and Assembly of Drug Dispensers and Containers
Application: 17/150,905 →
Publication: US 2022/0227566
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 23, 2003
From: SCHMITT, JEFFREY D.; DULL, GARY M.; GENEVOIS-BARELLA, ARIELLE; CAPET, MARC
To: TARGACEPT, INC.
Reel/Frame 013824/0075 →
Assignment of Assignor's Interest Jul 24, 2009
From: GENEVOIS-BORELLA, ARIELLE; CAPET, MARC; CHEVE, MICHEL
To: AVENTIS PHARMA S.A.
Reel/Frame 023005/0446 →
Assignment of Assignor's Interest Jul 24, 2009
From: AVENTIS PHARMA S.A.
To: TARGACEPT, INC.
Reel/Frame 023001/0344 →
Assignment of Assignor's Interest Jul 24, 2009
From: SCHMITT, JEFFREY DANIEL; DULL, GARY MAURICE; MILLER, CRAIG HARRISON
To: TARGACEPT, INC.
Reel/Frame 023000/0749 →
Assignment of Assignor's Interest Apr 14, 2011
From: AVENTIS PHARMA S.A.
To: TARGACEPT, INC.
Reel/Frame 026125/0389 →
Assignment of Assignor's Interest Apr 14, 2011
From: GENEVOIS-BORELLA, ARIELLE; CAPET, MARC; CHEVE, MICHEL
To: AVENTIS PHARMA S.A.
Reel/Frame 026125/0383 →
Assignment of Assignor's Interest Apr 14, 2011
From: SCHMITT, JEFFREY DANIEL; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 026125/0386 →
Assignment of Assignor's Interest Nov 17, 2015
From: ACKERMANN, DOUGLAS MICHAEL, JR; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 037059/0288 →
Assignment of Assignor's Interest Nov 17, 2015
From: ACKERMANN, DOUGLAS MICHAEL, JR; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 037058/0647 →
Assignment of Assignor's Interest Nov 17, 2015
From: ACKERMANN, DOUGLAS MICHAEL, JR; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 037059/0399 →
Assignment of Assignor's Interest Nov 17, 2015
From: ACKERMANN, DOUGLAS MICHAEL, JR; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 037058/0715 →
Assignment of Assignor's Interest Nov 17, 2016
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 040364/0118 →
Change of Name Nov 17, 2016
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 040645/0359 →
Assignment of Assignor's Interest Nov 17, 2016
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 040645/0282 →
Assignment of Assignor's Interest Jan 9, 2017
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 040904/0482 →
Change of Name Jan 13, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041044/0211 →
Assignment of Assignor's Interest Jan 13, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041043/0769 →
Assignment of Assignor's Interest Feb 16, 2017
From: ACKERMANN, DOUGLAS MICHAEL, JR.; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041818/0459 →
Assignment of Assignor's Interest Feb 27, 2017
From: AVENTIS PHARMA S.A.
To: TARGACEPT, INC.
Reel/Frame 041386/0202 →
Assignment of Assignor's Interest Feb 27, 2017
From: SCHMITT, JEFFREY DANIEL; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 041385/0850 →
Assignment of Assignor's Interest Feb 27, 2017
From: GENEVOIS-BORELLA, ARIELLE; CAPET, MARC; CHEVE, MICHEL
To: AVENTIS PHARMA S.A.
Reel/Frame 041822/0587 →
Assignment of Assignor's Interest Feb 27, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041822/0678 →
Change of Name Feb 27, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041822/0956 →
Corrective Assignment to Correct the Misspelling of First Assignor's Last Name and Outdated Assignee Address Previously Recorded on Reel 037059 Frame 0399. Assignor(S) Hereby Confirms the Assignment. Apr 3, 2017
From: ACKERMANN, DOUGLAS MICHAEL, JR.; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 042140/0895 →
Corrective Assignment to Correct the Misspelling of First Assignor's Last Name and Outdated Assignee Address Previously Recorded on Reel 037058 Frame 0647. Assignor(S) Hereby Confirms the Assignment. Apr 3, 2017
From: ACKERMANN, DOUGLAS MICHAEL, JR.; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 042140/0328 →